Back

A review of current landscape and definition of septic cardiomyopathy

26 August 2023 (09:15 - 09:50)
Organised by: Logo
Congress Presentation Part of: Epidemiology, prognosis, and outcomes in acute heart failure Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Shanthosh Sivapathan

Nepean Hospital, Sydney (Australia)

6 More presentations in this session

Presentation thumbnail
In-hospital Prognostic Value of TAPSE/sPAP in Patients Hospitalized for Acute Heart Failure
Doctor C. Fauvel (Rouen, FR)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of improvement in quality of life after discharge in patients with ADHF with preserved ejection fraction regardless of the course of HF -PURSUIT-HFpEF registry.
Mr T. Kondo (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
The classification shifting and outcomes of DELIVER-type patients with acute heart failure and preserved ejection fraction
Doctor L. Ling (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
A universal electronic consultation programme at the cardiology department after general practitioner referrals improves healthcare outcomes in patients with health failure
Doctor D. Garcia Vega (Ourense, ES)
Abstract Slides Video
Presentation thumbnail
Impact of atrial fibrillation on mortality and non-fatal cardiovascular outcomes in 152 638 patients admitted with congestive cardiac failure: a statewide population-linkage study
Doctor J. Ne (Concord, AU)
Abstract Slides Video

Access the full session

Session thumbnail
Epidemiology, prognosis, and outcomes in acute heart failure

The Event

Event poster

ESC Congress 2023

26 August 2023 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Unveiling the population dynamics of sepsis cardiomyopathy: a comprehensive evaluation
thumbnail
Congress Presentation
Sepsis-induced cardiac dysfunction: echocardiographic patterns and outcome implications
thumbnail
Congress Presentation
S100A8/A9 inhibition prevents septic cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources